214 related articles for article (PubMed ID: 20532772)
1. Clinicopathologic characteristics of colorectal cancer patients with synchronous and metachronous gastric cancer.
Yoon SN; Oh ST; Lim SB; Kim TW; Kim JH; Yu CS; Kim JC
World J Surg; 2010 Sep; 34(9):2168-76. PubMed ID: 20532772
[TBL] [Abstract][Full Text] [Related]
2. Dual primary gastric and colorectal cancer: is the prognosis better for synchronous or metachronous?
Watanabe M; Kochi M; Fujii M; Kaiga T; Mihara Y; Funada T; Tamegai H; Shimizu H; Takayama T
Am J Clin Oncol; 2012 Oct; 35(5):407-10. PubMed ID: 21659834
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
[TBL] [Abstract][Full Text] [Related]
4. Synchronous and metachronous primary malignancies in organs other than the stomach in patients with early gastric cancer.
Ikeguchi M; Ohfuji S; Oka A; Tsujitani S; Maeda M; Kaibara N
Hepatogastroenterology; 1995; 42(5):672-6. PubMed ID: 8751233
[TBL] [Abstract][Full Text] [Related]
5. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features and prognosis of synchronous and metachronous multiple primary colorectal cancer.
Zhang C; Cui M; Xing J; Yang H; Yao Z; Zhang N; Su X
Clin Transl Oncol; 2021 Feb; 23(2):335-343. PubMed ID: 32592156
[TBL] [Abstract][Full Text] [Related]
7. Synchronous and metachronous colorectal cancers: distinct disease entities or different disease courses?
Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
Hepatogastroenterology; 2015; 62(138):286-90. PubMed ID: 25916050
[TBL] [Abstract][Full Text] [Related]
8. [Impact of time of occurrence of liver metastases (synchronous vs. metachronous) on early postoperative outcome and long-term survival of colorectal cancer patients].
Bova R; Kamphues C; Neuhaus P; Puhl G
Zentralbl Chir; 2014 Apr; 139(2):220-5. PubMed ID: 23846535
[TBL] [Abstract][Full Text] [Related]
9. Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses?
Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
Hepatogastroenterology; 2015 Jun; 62(140):838-42. PubMed ID: 26902012
[TBL] [Abstract][Full Text] [Related]
10. Impact of absence of consensual cutoff time distinguishing between synchronous and metachronous metastases: illustration with colorectal cancer.
Willem H; Jooste V; Boussari O; Romain G; Bouvier AM
Eur J Cancer Prev; 2019 May; 28(3):167-172. PubMed ID: 29738323
[TBL] [Abstract][Full Text] [Related]
11. METACHRONOUS COLORECTAL LIVER METASTASES HAS BETTER PROGNOSIS - IS IT TRUE?
Quireze Junior C; Brasil AMS; Morais LK; Campion ERL; Taveira EJF; Rassi MC
Arq Gastroenterol; 2018; 55(3):258-263. PubMed ID: 30540088
[TBL] [Abstract][Full Text] [Related]
12. Synchronous and metachronous neoplasms in gastric cancer patients: a 23-year study.
Ławniczak M; Gawin A; Jaroszewicz-Heigelmann H; Rogoza-Mateja W; Raszeja-Wyszomirska J; Białek A; Karpińska-Kaczmarczyk K; Starzyńska T
World J Gastroenterol; 2014 Jun; 20(23):7480-7. PubMed ID: 24966619
[TBL] [Abstract][Full Text] [Related]
13. Synchronous and "early" metachronous colorectal adenocarcinoma: analysis of prognosis and current trends.
Chen HS; Sheen-Chen SM
Dis Colon Rectum; 2000 Aug; 43(8):1093-9. PubMed ID: 10950007
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for metachronous adenoma in the residual colon of patients undergoing curative surgery for colorectal cancer.
Patel A; Williams N; Parsons N; Ali O; Peters F; Ranat R; Shah J; Spector E; Arasaradnam RP
Int J Colorectal Dis; 2017 Nov; 32(11):1609-1616. PubMed ID: 28828520
[TBL] [Abstract][Full Text] [Related]
15. Synchronous and metachronous cancers in patients with gastric cancer.
Eom BW; Lee HJ; Yoo MW; Cho JJ; Kim WH; Yang HK; Lee KU
J Surg Oncol; 2008 Aug; 98(2):106-10. PubMed ID: 18452218
[TBL] [Abstract][Full Text] [Related]
16. Outcome after simultaneous resection of gastric primary tumour and synchronous liver metastases: survival analysis of a single-center experience in China.
Liu Q; Bi JJ; Tian YT; Feng Q; Zheng ZX; Wang Z
Asian Pac J Cancer Prev; 2015; 16(4):1665-9. PubMed ID: 25743789
[TBL] [Abstract][Full Text] [Related]
17. Synchronous polyps predict metachronous colorectal lesions after curative resection of colorectal cancer.
Pozza A; Ruffolo C; Fiorot A; Padoan L; Erroi F; Massani M; Caratozzolo E; Bonariol L; Ferrara F; Norberto L; Castoro C; Bassi N; Scarpa M
Acta Chir Belg; 2016 Aug; 116(4):225-230. PubMed ID: 27426670
[TBL] [Abstract][Full Text] [Related]
18. Altered DNA mismatch repair expression in synchronous and metachronous colorectal cancers.
Aslanian HR; Burgart LJ; Harrington JJ; Mahoney DW; Zinsmeister AR; Thibodeau SN; Ahlquist DA
Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1385-8. PubMed ID: 18639494
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for synchronous or metachronous tumor development after endoscopic resection of gastric neoplasms.
Lim JH; Kim SG; Choi J; Im JP; Kim JS; Jung HC
Gastric Cancer; 2015 Oct; 18(4):817-23. PubMed ID: 25326338
[TBL] [Abstract][Full Text] [Related]
20. Synchronous colorectal carcinoma: predisposing factors and characteristics.
Chin CC; Kuo YH; Chiang JM
Colorectal Dis; 2019 Apr; 21(4):432-440. PubMed ID: 30578740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
